BeOne Medicines (ONC) Shares Issued (2015 - 2018)

BeOne Medicines (ONC) posted quarterly Shares Issued of $89.9 million for Q2 2018, down 25.57% quarter-over-quarter from $120.8 million in Q1 2018.

BeOne Medicines (ONC) Shares Issued (2015 - 2018) Analysis & Trends

BeOne Medicines (ONC) has reported Shares Issued for 4 consecutive years, with $89.9 million the latest figure, recorded in Q2 2018.

In Q2 2018, Shares Issued changed N/A year-over-year to $89.9 million; the TTM figure through Jun 2018 stood at $89.9 million (changed N/A YoY), while the FY2017 annual figure was $127.0 million, up 64.77% from the prior year.
Shares Issued eased to $89.9 million in Q2 2018 per ONC's latest filing, from $120.8 million in the prior quarter.
Across five years, Shares Issued topped out at $130.8 million in Q3 2017 and bottomed at $44.1 million in Q4 2015.
Historically, Shares Issued has averaged $98.3 million across 4 years, with a median of $105.4 million in 2018.
Annual changes were most pronounced in 2016 — Shares Issued jumped 74.74% — and 2017, when it jumped 64.77%.
BeOne Medicines' Shares Issued stood at $44.1 million in 2015, then surged by 74.74% to $77.1 million in 2016, then surged by 64.77% to $127.0 million in 2017, then decreased by 29.2% to $89.9 million in 2018.
Business Quant data shows ONC's Shares Issued at $89.9 million in Q2 2018, $120.8 million in Q1 2018, and $127.0 million in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	18.36 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Roivant Sciences	26.16 Bn	26.85 Bn	1.16 Mn	-

Download Data